Fig. 5From: A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancerOverall survival stratified by the combined scoring of CHAF1A with classic biomarkers in gastric cancer. A and B: the combined scoring of CHAF1A with MSI (A) and TMB (B) in TCGA. C and D: the combined scoring of CHAF1A with MSI (C) and TMB (D) in ACRG. E and F: the combined scoring of CHAF1A with MSI (E) and TMB (F) in AHJU. AHJU Affiliated Hospital of Jiangsu University, ACRG Asian Cancer Research Group, TCGA The Cancer Genome Atlas, MSI microsatellite instability, TMB tumor mutation burdenBack to article page